Vericel and SAP stocks show upward momentum

Vericel Corporation (VCEL) shares recently moved above their 200-day moving average, trading at approximately $40.15. Following an earnings report on July 30, the biotechnology company reported earnings per share of $0.04, exceeding analyst estimates of a $0.03 loss. Revenue for the quarter reached $77.46 million, surpassing the expected $72.70 million. Several analysts have issued positive outlooks, including Truist Financial and TD Cowen, both setting price targets of $58.00, while HC Wainwright issued a $70.00 price objective.

SAP SE has shown signs of a recovery after a significant decline, with its stock price rising to approximately €183.92. The stock has broken out of a downward trend channel and surpassed previous resistance zones between €153.00 and €175.00. Technical analysis suggests that while the momentum is positive, the stock faces upcoming resistance between €197.00 and €202.00. A sustained move above this range could potentially lead toward the €222.60 mark.